nodes	percent_of_prediction	percent_of_DWPC	metapath
Fingolimod—CYP3A4—bone cancer	0.666	1	CbGaD
Fingolimod—Posterior reversible encephalopathy syndrome—Cisplatin—bone cancer	0.00697	0.102	CcSEcCtD
Fingolimod—X-linked lymphoproliferative syndrome—Methotrexate—bone cancer	0.00464	0.0679	CcSEcCtD
Fingolimod—Lymphoproliferative disorder—Methotrexate—bone cancer	0.00464	0.0679	CcSEcCtD
Fingolimod—S1PR5—G alpha (i) signalling events—RGS1—bone cancer	0.00201	0.00757	CbGpPWpGaD
Fingolimod—S1PR3—G alpha (i) signalling events—GRM4—bone cancer	0.00201	0.00757	CbGpPWpGaD
Fingolimod—CYP2E1—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.002	0.00753	CbGpPWpGaD
Fingolimod—CYP4F12—Tryptophan metabolism—MDM2—bone cancer	0.00187	0.00704	CbGpPWpGaD
Fingolimod—S1PR1—G alpha (i) signalling events—RGS1—bone cancer	0.00183	0.00688	CbGpPWpGaD
Fingolimod—S1PR1—G alpha (i) signalling events—GRM4—bone cancer	0.00183	0.00688	CbGpPWpGaD
Fingolimod—Lymphoma—Methotrexate—bone cancer	0.0018	0.0263	CcSEcCtD
Fingolimod—CYP4F2—Arachidonic acid metabolism—PTGS2—bone cancer	0.00146	0.00548	CbGpPWpGaD
Fingolimod—CYP2D6—Codeine and Morphine Metabolism—CYP3A4—bone cancer	0.00142	0.00537	CbGpPWpGaD
Fingolimod—CYP2D6—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00142	0.00534	CbGpPWpGaD
Fingolimod—CYP4F12—Biological oxidations—CYP3A4—bone cancer	0.00142	0.00534	CbGpPWpGaD
Fingolimod—CYP4F12—Metapathway biotransformation—CYP3A4—bone cancer	0.0014	0.00526	CbGpPWpGaD
Fingolimod—Infection—Carboplatin—bone cancer	0.00138	0.0202	CcSEcCtD
Fingolimod—Liver injury—Cisplatin—bone cancer	0.00136	0.0199	CcSEcCtD
Fingolimod—SPHK1—Metabolism of proteins—MOGS—bone cancer	0.00134	0.00503	CbGpPWpGaD
Fingolimod—S1PR4—GPCR ligand binding—GRM4—bone cancer	0.00126	0.00476	CbGpPWpGaD
Fingolimod—CYP4F2—Biological oxidations—CYP3A4—bone cancer	0.00122	0.00461	CbGpPWpGaD
Fingolimod—S1PR3—GPCR ligand binding—GRM4—bone cancer	0.00122	0.00459	CbGpPWpGaD
Fingolimod—S1PR5—GPCR ligand binding—GRM4—bone cancer	0.00122	0.00459	CbGpPWpGaD
Fingolimod—CYP4F12—Biological oxidations—GSTP1—bone cancer	0.00121	0.00456	CbGpPWpGaD
Fingolimod—CYP4F2—Metapathway biotransformation—CYP3A4—bone cancer	0.00121	0.00454	CbGpPWpGaD
Fingolimod—CYP4F12—Metapathway biotransformation—GSTP1—bone cancer	0.00119	0.0045	CbGpPWpGaD
Fingolimod—CYP2E1—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.00115	0.00434	CbGpPWpGaD
Fingolimod—Lymphopenia—Epirubicin—bone cancer	0.00115	0.0168	CcSEcCtD
Fingolimod—S1PR1—GPCR ligand binding—GRM4—bone cancer	0.00111	0.00416	CbGpPWpGaD
Fingolimod—S1PR4—GPCR ligand binding—GRM1—bone cancer	0.0011	0.00413	CbGpPWpGaD
Fingolimod—S1PR1—Fc-epsilon receptor I signaling in mast cells—JUN—bone cancer	0.00109	0.00409	CbGpPWpGaD
Fingolimod—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.00108	0.00407	CbGpPWpGaD
Fingolimod—Lymphopenia—Doxorubicin—bone cancer	0.00106	0.0156	CcSEcCtD
Fingolimod—S1PR5—GPCR ligand binding—GRM1—bone cancer	0.00106	0.00398	CbGpPWpGaD
Fingolimod—S1PR3—GPCR ligand binding—GRM1—bone cancer	0.00106	0.00398	CbGpPWpGaD
Fingolimod—CYP4F2—Biological oxidations—GSTP1—bone cancer	0.00105	0.00394	CbGpPWpGaD
Fingolimod—CYP4F2—Metapathway biotransformation—GSTP1—bone cancer	0.00103	0.00389	CbGpPWpGaD
Fingolimod—CYP2E1—Xenobiotics—CYP3A4—bone cancer	0.000965	0.00363	CbGpPWpGaD
Fingolimod—SPHK1—Fc-epsilon receptor I signaling in mast cells—JUN—bone cancer	0.000962	0.00362	CbGpPWpGaD
Fingolimod—S1PR1—GPCR ligand binding—GRM1—bone cancer	0.000958	0.00361	CbGpPWpGaD
Fingolimod—CYP2E1—Tamoxifen metabolism—CYP3A4—bone cancer	0.000928	0.00349	CbGpPWpGaD
Fingolimod—CYP3A4—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000927	0.00349	CbGpPWpGaD
Fingolimod—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000872	0.00329	CbGpPWpGaD
Fingolimod—CYP2E1—Metapathway biotransformation—CYP4V2—bone cancer	0.00086	0.00324	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—NDUFA12—bone cancer	0.000849	0.0032	CbGpPWpGaD
Fingolimod—Cerebrovascular accident—Cisplatin—bone cancer	0.000847	0.0124	CcSEcCtD
Fingolimod—S1PR1—PDGFR-beta signaling pathway—BRAF—bone cancer	0.000841	0.00317	CbGpPWpGaD
Fingolimod—Herpes zoster—Methotrexate—bone cancer	0.000833	0.0122	CcSEcCtD
Fingolimod—CYP2D6—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.000818	0.00308	CbGpPWpGaD
Fingolimod—Herpes zoster—Epirubicin—bone cancer	0.00078	0.0114	CcSEcCtD
Fingolimod—S1PR4—GPCR ligand binding—SMO—bone cancer	0.000773	0.00291	CbGpPWpGaD
Fingolimod—Aspartate aminotransferase increased—Cisplatin—bone cancer	0.000747	0.011	CcSEcCtD
Fingolimod—SPHK1—PDGFR-beta signaling pathway—BRAF—bone cancer	0.000744	0.0028	CbGpPWpGaD
Fingolimod—S1PR3—GPCR ligand binding—SMO—bone cancer	0.000744	0.0028	CbGpPWpGaD
Fingolimod—S1PR5—GPCR ligand binding—SMO—bone cancer	0.000744	0.0028	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—NDUFA12—bone cancer	0.000733	0.00276	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of proteins—TUBB4B—bone cancer	0.000732	0.00276	CbGpPWpGaD
Fingolimod—Herpes zoster—Doxorubicin—bone cancer	0.000721	0.0106	CcSEcCtD
Fingolimod—S1PR4—GPCR downstream signaling—GRM4—bone cancer	0.000715	0.00269	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—RGS1—bone cancer	0.000715	0.00269	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—NT5C3A—bone cancer	0.000704	0.00265	CbGpPWpGaD
Fingolimod—Liver injury—Epirubicin—bone cancer	0.000698	0.0102	CcSEcCtD
Fingolimod—S1PR3—GPCR downstream signaling—RGS1—bone cancer	0.000688	0.00259	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—GRM4—bone cancer	0.000688	0.00259	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—GRM4—bone cancer	0.000688	0.00259	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—RGS1—bone cancer	0.000688	0.00259	CbGpPWpGaD
Fingolimod—CYP2D6—Xenobiotics—CYP3A4—bone cancer	0.000684	0.00258	CbGpPWpGaD
Fingolimod—S1PR1—GPCR ligand binding—SMO—bone cancer	0.000675	0.00254	CbGpPWpGaD
Fingolimod—Hepatic enzyme increased—Methotrexate—bone cancer	0.000663	0.00972	CcSEcCtD
Fingolimod—CYP2D6—Tamoxifen metabolism—CYP3A4—bone cancer	0.000658	0.00248	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—RGS1—bone cancer	0.000649	0.00244	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—GRM4—bone cancer	0.000649	0.00244	CbGpPWpGaD
Fingolimod—Liver injury—Doxorubicin—bone cancer	0.000646	0.00946	CcSEcCtD
Fingolimod—SPHK1—Metabolism of proteins—TUBB2A—bone cancer	0.000632	0.00238	CbGpPWpGaD
Fingolimod—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000631	0.00238	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—NDUFA12—bone cancer	0.00063	0.00237	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—RGS1—bone cancer	0.000625	0.00235	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—GRM4—bone cancer	0.000625	0.00235	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—RGS1—bone cancer	0.000625	0.00235	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—GRM4—bone cancer	0.000625	0.00235	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—RGS1—bone cancer	0.000625	0.00235	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—GRM4—bone cancer	0.000625	0.00235	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—GRM1—bone cancer	0.00062	0.00233	CbGpPWpGaD
Fingolimod—S1PR1—PDGFR-beta signaling pathway—JUN—bone cancer	0.000612	0.00231	CbGpPWpGaD
Fingolimod—CYP2D6—Metapathway biotransformation—CYP4V2—bone cancer	0.00061	0.0023	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—NT5C3A—bone cancer	0.000607	0.00229	CbGpPWpGaD
Fingolimod—Atrioventricular block—Epirubicin—bone cancer	0.000605	0.00887	CcSEcCtD
Fingolimod—S1PR3—GPCR downstream signaling—GRM1—bone cancer	0.000597	0.00225	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—GRM1—bone cancer	0.000597	0.00225	CbGpPWpGaD
Fingolimod—Bradycardia—Cisplatin—bone cancer	0.000584	0.00857	CcSEcCtD
Fingolimod—S1PR1—Signaling by GPCR—GRM4—bone cancer	0.000567	0.00214	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—RGS1—bone cancer	0.000567	0.00214	CbGpPWpGaD
Fingolimod—Connective tissue disorder—Cisplatin—bone cancer	0.000564	0.00827	CcSEcCtD
Fingolimod—S1PR4—Signaling by GPCR—GRM1—bone cancer	0.000563	0.00212	CbGpPWpGaD
Fingolimod—Atrioventricular block—Doxorubicin—bone cancer	0.00056	0.00821	CcSEcCtD
Fingolimod—SPHK1—PDGFR-beta signaling pathway—JUN—bone cancer	0.000542	0.00204	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—GRM1—bone cancer	0.000542	0.00204	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—GRM1—bone cancer	0.000542	0.00204	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—GRM1—bone cancer	0.000542	0.00204	CbGpPWpGaD
Fingolimod—Eye disorder—Cisplatin—bone cancer	0.000537	0.00786	CcSEcCtD
Fingolimod—Cardiac disorder—Cisplatin—bone cancer	0.000533	0.00781	CcSEcCtD
Fingolimod—SPHK1—Metabolism—NT5C3A—bone cancer	0.000522	0.00197	CbGpPWpGaD
Fingolimod—Mediastinal disorder—Cisplatin—bone cancer	0.000517	0.00758	CcSEcCtD
Fingolimod—Alopecia—Cisplatin—bone cancer	0.000507	0.00744	CcSEcCtD
Fingolimod—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000501	0.00189	CbGpPWpGaD
Fingolimod—CYP2E1—Tryptophan metabolism—CYP3A4—bone cancer	0.000495	0.00187	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—GRM1—bone cancer	0.000492	0.00185	CbGpPWpGaD
Fingolimod—Eczema—Epirubicin—bone cancer	0.000474	0.00695	CcSEcCtD
Fingolimod—Eye pain—Epirubicin—bone cancer	0.000472	0.00692	CcSEcCtD
Fingolimod—Vision blurred—Cisplatin—bone cancer	0.000471	0.0069	CcSEcCtD
Fingolimod—Cerebrovascular accident—Methotrexate—bone cancer	0.000465	0.00681	CcSEcCtD
Fingolimod—Leukopenia—Cisplatin—bone cancer	0.000447	0.00656	CcSEcCtD
Fingolimod—SPHK1—Metabolism of proteins—EIF2S1—bone cancer	0.000441	0.00166	CbGpPWpGaD
Fingolimod—Eczema—Doxorubicin—bone cancer	0.000439	0.00643	CcSEcCtD
Fingolimod—Eye pain—Doxorubicin—bone cancer	0.000437	0.0064	CcSEcCtD
Fingolimod—Cerebrovascular accident—Epirubicin—bone cancer	0.000435	0.00637	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.000423	0.00619	CcSEcCtD
Fingolimod—Liver function test abnormal—Methotrexate—bone cancer	0.00042	0.00616	CcSEcCtD
Fingolimod—Migraine—Epirubicin—bone cancer	0.00042	0.00615	CcSEcCtD
Fingolimod—Cardiac arrest—Epirubicin—bone cancer	0.000405	0.00594	CcSEcCtD
Fingolimod—Infection—Cisplatin—bone cancer	0.000405	0.00594	CcSEcCtD
Fingolimod—Cerebrovascular accident—Doxorubicin—bone cancer	0.000402	0.0059	CcSEcCtD
Fingolimod—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000401	0.00151	CbGpPWpGaD
Fingolimod—Nervous system disorder—Cisplatin—bone cancer	0.0004	0.00586	CcSEcCtD
Fingolimod—S1PR4—GPCR downstream signaling—GNA11—bone cancer	0.000399	0.0015	CbGpPWpGaD
Fingolimod—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	0.000399	0.0015	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—SMO—bone cancer	0.000396	0.00149	CbGpPWpGaD
Fingolimod—Skin disorder—Cisplatin—bone cancer	0.000396	0.00581	CcSEcCtD
Fingolimod—CYP2E1—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000395	0.00149	CbGpPWpGaD
Fingolimod—Liver function test abnormal—Epirubicin—bone cancer	0.000393	0.00577	CcSEcCtD
Fingolimod—Migraine—Doxorubicin—bone cancer	0.000388	0.00569	CcSEcCtD
Fingolimod—S1PR5—GPCR downstream signaling—GNA11—bone cancer	0.000384	0.00145	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—GNA11—bone cancer	0.000384	0.00145	CbGpPWpGaD
Fingolimod—Aspartate aminotransferase increased—Epirubicin—bone cancer	0.000384	0.00563	CcSEcCtD
Fingolimod—S1PR4—Signaling Pathways—GRM4—bone cancer	0.000383	0.00144	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—RGS1—bone cancer	0.000383	0.00144	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—SMO—bone cancer	0.000382	0.00144	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—SMO—bone cancer	0.000382	0.00144	CbGpPWpGaD
Fingolimod—Hypotension—Cisplatin—bone cancer	0.000381	0.00559	CcSEcCtD
Fingolimod—Alanine aminotransferase increased—Epirubicin—bone cancer	0.000376	0.00551	CcSEcCtD
Fingolimod—Cardiac arrest—Doxorubicin—bone cancer	0.000375	0.0055	CcSEcCtD
Fingolimod—S1PR3—Signaling Pathways—GRM4—bone cancer	0.000369	0.00139	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—RGS1—bone cancer	0.000369	0.00139	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—GRM4—bone cancer	0.000369	0.00139	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—RGS1—bone cancer	0.000369	0.00139	CbGpPWpGaD
Fingolimod—Influenza—Epirubicin—bone cancer	0.000368	0.0054	CcSEcCtD
Fingolimod—Paraesthesia—Cisplatin—bone cancer	0.000366	0.00537	CcSEcCtD
Fingolimod—Liver function test abnormal—Doxorubicin—bone cancer	0.000364	0.00534	CcSEcCtD
Fingolimod—Dyspnoea—Cisplatin—bone cancer	0.000364	0.00533	CcSEcCtD
Fingolimod—S1PR4—Signaling by GPCR—GNA11—bone cancer	0.000363	0.00137	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—IL3—bone cancer	0.000362	0.00136	CbGpPWpGaD
Fingolimod—Aspartate aminotransferase increased—Doxorubicin—bone cancer	0.000355	0.0052	CcSEcCtD
Fingolimod—Bronchitis—Epirubicin—bone cancer	0.000354	0.00519	CcSEcCtD
Fingolimod—Pneumonia—Methotrexate—bone cancer	0.000353	0.00517	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Cisplatin—bone cancer	0.000352	0.00516	CcSEcCtD
Fingolimod—Infestation—Methotrexate—bone cancer	0.000351	0.00514	CcSEcCtD
Fingolimod—Infestation NOS—Methotrexate—bone cancer	0.000351	0.00514	CcSEcCtD
Fingolimod—Depression—Methotrexate—bone cancer	0.00035	0.00513	CcSEcCtD
Fingolimod—S1PR3—Signaling by GPCR—GNA11—bone cancer	0.000349	0.00131	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—GNA11—bone cancer	0.000349	0.00131	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—GNA11—bone cancer	0.000349	0.00131	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—IL3—bone cancer	0.000348	0.00131	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—IL3—bone cancer	0.000348	0.00131	CbGpPWpGaD
Fingolimod—Alanine aminotransferase increased—Doxorubicin—bone cancer	0.000348	0.0051	CcSEcCtD
Fingolimod—S1PR1—Signaling by GPCR—SMO—bone cancer	0.000347	0.00131	CbGpPWpGaD
Fingolimod—Influenza—Doxorubicin—bone cancer	0.000341	0.005	CcSEcCtD
Fingolimod—S1PR1—Signaling Pathways—GRM4—bone cancer	0.000335	0.00126	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—RGS1—bone cancer	0.000335	0.00126	CbGpPWpGaD
Fingolimod—Weight decreased—Epirubicin—bone cancer	0.000333	0.00488	CcSEcCtD
Fingolimod—S1PR4—Signaling Pathways—GRM1—bone cancer	0.000332	0.00125	CbGpPWpGaD
Fingolimod—Pneumonia—Epirubicin—bone cancer	0.00033	0.00484	CcSEcCtD
Fingolimod—S1PR4—Signaling by GPCR—IL3—bone cancer	0.000329	0.00124	CbGpPWpGaD
Fingolimod—Infestation—Epirubicin—bone cancer	0.000328	0.00481	CcSEcCtD
Fingolimod—Infestation NOS—Epirubicin—bone cancer	0.000328	0.00481	CcSEcCtD
Fingolimod—Bronchitis—Doxorubicin—bone cancer	0.000328	0.0048	CcSEcCtD
Fingolimod—CYP2E1—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000325	0.00122	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—GRM1—bone cancer	0.00032	0.00121	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—GRM1—bone cancer	0.00032	0.00121	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—GNA11—bone cancer	0.000317	0.00119	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—IL3—bone cancer	0.000316	0.00119	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—IL3—bone cancer	0.000316	0.00119	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—IL3—bone cancer	0.000316	0.00119	CbGpPWpGaD
Fingolimod—Weight decreased—Doxorubicin—bone cancer	0.000308	0.00452	CcSEcCtD
Fingolimod—CYP4F12—Metabolism—ENO2—bone cancer	0.000308	0.00116	CbGpPWpGaD
Fingolimod—Sinusitis—Epirubicin—bone cancer	0.000308	0.00452	CcSEcCtD
Fingolimod—Pneumonia—Doxorubicin—bone cancer	0.000306	0.00448	CcSEcCtD
Fingolimod—Infestation NOS—Doxorubicin—bone cancer	0.000304	0.00445	CcSEcCtD
Fingolimod—Infestation—Doxorubicin—bone cancer	0.000304	0.00445	CcSEcCtD
Fingolimod—Bradycardia—Epirubicin—bone cancer	0.0003	0.0044	CcSEcCtD
Fingolimod—SPHK1—Signaling Pathways—RGS1—bone cancer	0.000297	0.00112	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—GRM4—bone cancer	0.000297	0.00112	CbGpPWpGaD
Fingolimod—Eye disorder—Methotrexate—bone cancer	0.000294	0.00432	CcSEcCtD
Fingolimod—Asthenia—Cisplatin—bone cancer	0.000293	0.00429	CcSEcCtD
Fingolimod—Cardiac disorder—Methotrexate—bone cancer	0.000292	0.00429	CcSEcCtD
Fingolimod—S1PR1—Signaling Pathways—GRM1—bone cancer	0.000291	0.00109	CbGpPWpGaD
Fingolimod—Connective tissue disorder—Epirubicin—bone cancer	0.00029	0.00425	CcSEcCtD
Fingolimod—S1PR1—Signaling by GPCR—IL3—bone cancer	0.000287	0.00108	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—DHFR—bone cancer	0.000286	0.00108	CbGpPWpGaD
Fingolimod—Angiopathy—Methotrexate—bone cancer	0.000286	0.00419	CcSEcCtD
Fingolimod—Sinusitis—Doxorubicin—bone cancer	0.000285	0.00418	CcSEcCtD
Fingolimod—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000284	0.00107	CbGpPWpGaD
Fingolimod—Mediastinal disorder—Methotrexate—bone cancer	0.000284	0.00416	CcSEcCtD
Fingolimod—CYP2D6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.00028	0.00106	CbGpPWpGaD
Fingolimod—Diarrhoea—Cisplatin—bone cancer	0.000279	0.00409	CcSEcCtD
Fingolimod—Alopecia—Methotrexate—bone cancer	0.000278	0.00408	CcSEcCtD
Fingolimod—Bradycardia—Doxorubicin—bone cancer	0.000278	0.00407	CcSEcCtD
Fingolimod—Mental disorder—Methotrexate—bone cancer	0.000276	0.00405	CcSEcCtD
Fingolimod—Eye disorder—Epirubicin—bone cancer	0.000276	0.00404	CcSEcCtD
Fingolimod—Cardiac disorder—Epirubicin—bone cancer	0.000274	0.00401	CcSEcCtD
Fingolimod—Connective tissue disorder—Doxorubicin—bone cancer	0.000268	0.00393	CcSEcCtD
Fingolimod—Angiopathy—Epirubicin—bone cancer	0.000268	0.00392	CcSEcCtD
Fingolimod—CYP4F12—Metabolism—GNA11—bone cancer	0.000267	0.00101	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—ENO2—bone cancer	0.000266	0.001	CbGpPWpGaD
Fingolimod—Mediastinal disorder—Epirubicin—bone cancer	0.000266	0.00389	CcSEcCtD
Fingolimod—Back pain—Methotrexate—bone cancer	0.000265	0.00389	CcSEcCtD
Fingolimod—Alopecia—Epirubicin—bone cancer	0.000261	0.00382	CcSEcCtD
Fingolimod—Vision blurred—Methotrexate—bone cancer	0.000258	0.00379	CcSEcCtD
Fingolimod—Mental disorder—Epirubicin—bone cancer	0.000258	0.00379	CcSEcCtD
Fingolimod—SPHK1—Signaling Pathways—GRM1—bone cancer	0.000257	0.000969	CbGpPWpGaD
Fingolimod—Eye disorder—Doxorubicin—bone cancer	0.000255	0.00374	CcSEcCtD
Fingolimod—Cardiac disorder—Doxorubicin—bone cancer	0.000253	0.00371	CcSEcCtD
Fingolimod—Back pain—Epirubicin—bone cancer	0.000248	0.00364	CcSEcCtD
Fingolimod—Angiopathy—Doxorubicin—bone cancer	0.000248	0.00363	CcSEcCtD
Fingolimod—CYP4F2—Metabolism—DHFR—bone cancer	0.000247	0.00093	CbGpPWpGaD
Fingolimod—Mediastinal disorder—Doxorubicin—bone cancer	0.000246	0.0036	CcSEcCtD
Fingolimod—Leukopenia—Methotrexate—bone cancer	0.000246	0.0036	CcSEcCtD
Fingolimod—CYP4F12—Metabolism—CYP3A4—bone cancer	0.000242	0.000913	CbGpPWpGaD
Fingolimod—Vision blurred—Epirubicin—bone cancer	0.000242	0.00355	CcSEcCtD
Fingolimod—Alopecia—Doxorubicin—bone cancer	0.000241	0.00353	CcSEcCtD
Fingolimod—Cough—Methotrexate—bone cancer	0.000239	0.00351	CcSEcCtD
Fingolimod—Mental disorder—Doxorubicin—bone cancer	0.000239	0.0035	CcSEcCtD
Fingolimod—S1PR4—Signaling Pathways—SMO—bone cancer	0.000234	0.000882	CbGpPWpGaD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000232	0.0034	CcSEcCtD
Fingolimod—CYP4F2—Metabolism—GNA11—bone cancer	0.000231	0.000869	CbGpPWpGaD
Fingolimod—CYP2D6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.00023	0.000868	CbGpPWpGaD
Fingolimod—Leukopenia—Epirubicin—bone cancer	0.00023	0.00337	CcSEcCtD
Fingolimod—Back pain—Doxorubicin—bone cancer	0.00023	0.00337	CcSEcCtD
Fingolimod—SPHK1—Metabolism—ENO2—bone cancer	0.000229	0.000861	CbGpPWpGaD
Fingolimod—CYP2E1—Tryptophan metabolism—MDM2—bone cancer	0.000228	0.000858	CbGpPWpGaD
Fingolimod—Palpitations—Epirubicin—bone cancer	0.000227	0.00332	CcSEcCtD
Fingolimod—S1PR3—Signaling Pathways—SMO—bone cancer	0.000225	0.000849	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—SMO—bone cancer	0.000225	0.000849	CbGpPWpGaD
Fingolimod—Cough—Epirubicin—bone cancer	0.000224	0.00328	CcSEcCtD
Fingolimod—Vision blurred—Doxorubicin—bone cancer	0.000224	0.00328	CcSEcCtD
Fingolimod—Infection—Methotrexate—bone cancer	0.000222	0.00326	CcSEcCtD
Fingolimod—Hypertension—Epirubicin—bone cancer	0.000222	0.00325	CcSEcCtD
Fingolimod—Nervous system disorder—Methotrexate—bone cancer	0.00022	0.00322	CcSEcCtD
Fingolimod—Skin disorder—Methotrexate—bone cancer	0.000217	0.00319	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000217	0.00318	CcSEcCtD
Fingolimod—S1PR4—Signaling Pathways—GNA11—bone cancer	0.000214	0.000807	CbGpPWpGaD
Fingolimod—Leukopenia—Doxorubicin—bone cancer	0.000213	0.00312	CcSEcCtD
Fingolimod—SPHK1—Metabolism—DHFR—bone cancer	0.000212	0.000799	CbGpPWpGaD
Fingolimod—Palpitations—Doxorubicin—bone cancer	0.00021	0.00308	CcSEcCtD
Fingolimod—Hypotension—Methotrexate—bone cancer	0.000209	0.00307	CcSEcCtD
Fingolimod—CYP4F2—Metabolism—CYP3A4—bone cancer	0.000209	0.000788	CbGpPWpGaD
Fingolimod—Infection—Epirubicin—bone cancer	0.000208	0.00305	CcSEcCtD
Fingolimod—CYP4F2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	0.000208	0.000784	CbGpPWpGaD
Fingolimod—Cough—Doxorubicin—bone cancer	0.000207	0.00304	CcSEcCtD
Fingolimod—CYP4F12—Metabolism—GSTP1—bone cancer	0.000207	0.000781	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—GNA11—bone cancer	0.000206	0.000777	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—GNA11—bone cancer	0.000206	0.000777	CbGpPWpGaD
Fingolimod—Nervous system disorder—Epirubicin—bone cancer	0.000205	0.00301	CcSEcCtD
Fingolimod—Hypertension—Doxorubicin—bone cancer	0.000205	0.00301	CcSEcCtD
Fingolimod—S1PR1—Signaling Pathways—SMO—bone cancer	0.000205	0.000771	CbGpPWpGaD
Fingolimod—Skin disorder—Epirubicin—bone cancer	0.000203	0.00298	CcSEcCtD
Fingolimod—Paraesthesia—Methotrexate—bone cancer	0.000201	0.00295	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000201	0.00294	CcSEcCtD
Fingolimod—Dyspnoea—Methotrexate—bone cancer	0.0002	0.00292	CcSEcCtD
Fingolimod—S1PR4—Signaling Pathways—ATF1—bone cancer	0.000199	0.00075	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—GNA11—bone cancer	0.000198	0.000747	CbGpPWpGaD
Fingolimod—Hypotension—Epirubicin—bone cancer	0.000196	0.00287	CcSEcCtD
Fingolimod—S1PR4—Signaling Pathways—IL3—bone cancer	0.000194	0.000732	CbGpPWpGaD
Fingolimod—Gastrointestinal disorder—Methotrexate—bone cancer	0.000193	0.00283	CcSEcCtD
Fingolimod—Fatigue—Methotrexate—bone cancer	0.000193	0.00283	CcSEcCtD
Fingolimod—Infection—Doxorubicin—bone cancer	0.000193	0.00282	CcSEcCtD
Fingolimod—S1PR5—Signaling Pathways—ATF1—bone cancer	0.000192	0.000722	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—ATF1—bone cancer	0.000192	0.000722	CbGpPWpGaD
Fingolimod—Nervous system disorder—Doxorubicin—bone cancer	0.00019	0.00279	CcSEcCtD
Fingolimod—Skin disorder—Doxorubicin—bone cancer	0.000188	0.00276	CcSEcCtD
Fingolimod—Paraesthesia—Epirubicin—bone cancer	0.000188	0.00276	CcSEcCtD
Fingolimod—S1PR1—Signaling Pathways—GNA11—bone cancer	0.000187	0.000705	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—IL3—bone cancer	0.000187	0.000704	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—IL3—bone cancer	0.000187	0.000704	CbGpPWpGaD
Fingolimod—Dyspnoea—Epirubicin—bone cancer	0.000187	0.00274	CcSEcCtD
Fingolimod—SPHK1—Signaling Pathways—SMO—bone cancer	0.000181	0.000683	CbGpPWpGaD
Fingolimod—Hypotension—Doxorubicin—bone cancer	0.000181	0.00265	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Epirubicin—bone cancer	0.000181	0.00265	CcSEcCtD
Fingolimod—Fatigue—Epirubicin—bone cancer	0.000181	0.00265	CcSEcCtD
Fingolimod—SPHK1—Metabolism of proteins—MMP2—bone cancer	0.00018	0.000679	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—CYP3A4—bone cancer	0.00018	0.000677	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—GSTP1—bone cancer	0.000179	0.000674	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	0.000179	0.000673	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—ATF1—bone cancer	0.000174	0.000656	CbGpPWpGaD
Fingolimod—Paraesthesia—Doxorubicin—bone cancer	0.000174	0.00255	CcSEcCtD
Fingolimod—Dyspnoea—Doxorubicin—bone cancer	0.000173	0.00253	CcSEcCtD
Fingolimod—CYP2E1—Biological oxidations—CYP3A4—bone cancer	0.000172	0.00065	CbGpPWpGaD
Fingolimod—CYP2E1—Metapathway biotransformation—CYP3A4—bone cancer	0.00017	0.000641	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—IL3—bone cancer	0.00017	0.000639	CbGpPWpGaD
Fingolimod—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000167	0.00245	CcSEcCtD
Fingolimod—Fatigue—Doxorubicin—bone cancer	0.000167	0.00245	CcSEcCtD
Fingolimod—S1PR4—Signaling Pathways—TGFBR2—bone cancer	0.000166	0.000626	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—GNA11—bone cancer	0.000166	0.000624	CbGpPWpGaD
Fingolimod—Asthenia—Methotrexate—bone cancer	0.000161	0.00235	CcSEcCtD
Fingolimod—S1PR3—Signaling Pathways—TGFBR2—bone cancer	0.00016	0.000602	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—TGFBR2—bone cancer	0.00016	0.000602	CbGpPWpGaD
Fingolimod—Pruritus—Methotrexate—bone cancer	0.000158	0.00232	CcSEcCtD
Fingolimod—S1PR4—Signaling Pathways—IGF1R—bone cancer	0.000156	0.000589	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—ATF1—bone cancer	0.000154	0.00058	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—GSTP1—bone cancer	0.000154	0.000579	CbGpPWpGaD
Fingolimod—Diarrhoea—Methotrexate—bone cancer	0.000153	0.00224	CcSEcCtD
Fingolimod—S1PR5—Signaling Pathways—IGF1R—bone cancer	0.00015	0.000567	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—IGF1R—bone cancer	0.00015	0.000567	CbGpPWpGaD
Fingolimod—Asthenia—Epirubicin—bone cancer	0.00015	0.0022	CcSEcCtD
Fingolimod—SPHK1—Signaling Pathways—IL3—bone cancer	0.00015	0.000566	CbGpPWpGaD
Fingolimod—Pruritus—Epirubicin—bone cancer	0.000148	0.00217	CcSEcCtD
Fingolimod—Dizziness—Methotrexate—bone cancer	0.000148	0.00217	CcSEcCtD
Fingolimod—CYP2E1—Biological oxidations—GSTP1—bone cancer	0.000148	0.000556	CbGpPWpGaD
Fingolimod—CYP2E1—Metapathway biotransformation—GSTP1—bone cancer	0.000145	0.000548	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—TGFBR2—bone cancer	0.000145	0.000547	CbGpPWpGaD
Fingolimod—Diarrhoea—Epirubicin—bone cancer	0.000143	0.0021	CcSEcCtD
Fingolimod—Headache—Methotrexate—bone cancer	0.00014	0.00206	CcSEcCtD
Fingolimod—Asthenia—Doxorubicin—bone cancer	0.000139	0.00204	CcSEcCtD
Fingolimod—Dizziness—Epirubicin—bone cancer	0.000139	0.00203	CcSEcCtD
Fingolimod—Pruritus—Doxorubicin—bone cancer	0.000137	0.00201	CcSEcCtD
Fingolimod—S1PR1—Signaling Pathways—IGF1R—bone cancer	0.000137	0.000515	CbGpPWpGaD
Fingolimod—Diarrhoea—Doxorubicin—bone cancer	0.000133	0.00194	CcSEcCtD
Fingolimod—Headache—Epirubicin—bone cancer	0.000131	0.00192	CcSEcCtD
Fingolimod—SPHK1—Signaling Pathways—TGFBR2—bone cancer	0.000128	0.000484	CbGpPWpGaD
Fingolimod—Dizziness—Doxorubicin—bone cancer	0.000128	0.00188	CcSEcCtD
Fingolimod—CYP2D6—Biological oxidations—CYP3A4—bone cancer	0.000122	0.000461	CbGpPWpGaD
Fingolimod—Headache—Doxorubicin—bone cancer	0.000121	0.00178	CcSEcCtD
Fingolimod—SPHK1—Signaling Pathways—IGF1R—bone cancer	0.000121	0.000455	CbGpPWpGaD
Fingolimod—CYP2D6—Metapathway biotransformation—CYP3A4—bone cancer	0.000121	0.000455	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—KIT—bone cancer	0.000113	0.000427	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—KIT—bone cancer	0.000109	0.000411	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—KIT—bone cancer	0.000109	0.000411	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—PTGS2—bone cancer	0.000107	0.000404	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—BRAF—bone cancer	0.000107	0.000401	CbGpPWpGaD
Fingolimod—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	0.000106	0.000398	CbGpPWpGaD
Fingolimod—CYP2D6—Biological oxidations—GSTP1—bone cancer	0.000105	0.000394	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—NDUFA12—bone cancer	0.000103	0.000389	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—EGFR—bone cancer	0.000103	0.000389	CbGpPWpGaD
Fingolimod—CYP2D6—Metapathway biotransformation—GSTP1—bone cancer	0.000103	0.000389	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—BRAF—bone cancer	0.000103	0.000386	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—BRAF—bone cancer	0.000103	0.000386	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—EGFR—bone cancer	9.94e-05	0.000374	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—EGFR—bone cancer	9.94e-05	0.000374	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—KIT—bone cancer	9.91e-05	0.000373	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—BRAF—bone cancer	9.31e-05	0.000351	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—PTGS2—bone cancer	9.27e-05	0.000349	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—EGFR—bone cancer	9.03e-05	0.00034	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—MDM2—bone cancer	8.93e-05	0.000336	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—KIT—bone cancer	8.77e-05	0.00033	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—MDM2—bone cancer	8.59e-05	0.000324	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—MDM2—bone cancer	8.59e-05	0.000324	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—NT5C3A—bone cancer	8.57e-05	0.000323	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—BRAF—bone cancer	8.24e-05	0.00031	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—PTGS2—bone cancer	7.96e-05	0.0003	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—MDM2—bone cancer	7.8e-05	0.000294	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—JUN—bone cancer	7.76e-05	0.000292	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—MMP9—bone cancer	7.55e-05	0.000284	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—JUN—bone cancer	7.47e-05	0.000281	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—JUN—bone cancer	7.47e-05	0.000281	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—NDUFA12—bone cancer	7.34e-05	0.000276	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—MMP9—bone cancer	7.27e-05	0.000274	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—MMP9—bone cancer	7.27e-05	0.000274	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—MDM2—bone cancer	6.9e-05	0.00026	CbGpPWpGaD
Fingolimod—CYP3A4—Biological oxidations—GSTP1—bone cancer	6.84e-05	0.000258	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—JUN—bone cancer	6.78e-05	0.000255	CbGpPWpGaD
Fingolimod—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	6.75e-05	0.000254	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—MMP9—bone cancer	6.6e-05	0.000249	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—EGFR—bone cancer	6.1e-05	0.00023	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—NT5C3A—bone cancer	6.08e-05	0.000229	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—JUN—bone cancer	6e-05	0.000226	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—EGFR—bone cancer	5.87e-05	0.000221	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—EGFR—bone cancer	5.87e-05	0.000221	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—MMP9—bone cancer	5.84e-05	0.00022	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—EGFR—bone cancer	5.33e-05	0.000201	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—TP53—bone cancer	5.12e-05	0.000193	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—TP53—bone cancer	4.93e-05	0.000186	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—TP53—bone cancer	4.93e-05	0.000186	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—NDUFA12—bone cancer	4.8e-05	0.000181	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—EGFR—bone cancer	4.72e-05	0.000178	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—TP53—bone cancer	4.48e-05	0.000169	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—NT5C3A—bone cancer	3.97e-05	0.00015	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—TP53—bone cancer	3.96e-05	0.000149	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ENO2—bone cancer	3.75e-05	0.000141	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—DHFR—bone cancer	3.48e-05	0.000131	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GNA11—bone cancer	3.25e-05	0.000123	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CYP3A4—bone cancer	2.95e-05	0.000111	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ENO2—bone cancer	2.66e-05	0.0001	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GSTP1—bone cancer	2.52e-05	9.5e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—DHFR—bone cancer	2.47e-05	9.31e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GNA11—bone cancer	2.31e-05	8.7e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CYP3A4—bone cancer	2.09e-05	7.88e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GSTP1—bone cancer	1.79e-05	6.74e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ENO2—bone cancer	1.74e-05	6.56e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—DHFR—bone cancer	1.62e-05	6.08e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GNA11—bone cancer	1.51e-05	5.69e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PTGS2—bone cancer	1.31e-05	4.92e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GSTP1—bone cancer	1.17e-05	4.41e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PTGS2—bone cancer	9.27e-06	3.49e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PTGS2—bone cancer	6.06e-06	2.28e-05	CbGpPWpGaD
